title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	characteristics_ch1.3	characteristics_ch1.4	molecule_ch1	extract_protocol_ch1	extract_protocol_ch1.1	extract_protocol_ch1.2	taxid_ch1	description	data_processing	data_processing.1	data_processing.2	data_processing.3	data_processing.4	data_processing.5	platform_id	contact_name	contact_email	contact_phone	contact_laboratory	contact_department	contact_institute	contact_address	contact_city	contact_state	contact_zip/postal_code	contact_country	data_row_count	instrument_model	library_selection	library_source	library_strategy	relation	relation.1	supplementary_file_1	cell culture media:ch1	cell line:ch1	cell type:ch1	gender:ch1	treatment:ch1	group
GSM3378079	LNCaP LP CS A	GSM3378079	Public on Jul 09 2019	Sep 06 2018	Jul 11 2019	SRA	1	LNCaP human prostate tumor cell line	Homo sapiens	gender: male	cell line: LNCaP (ATCC CRL-1740)	cell type: prostate cancer	cell culture media: cells were cultured in phenol-red free RPMI-1640 with 10% FBS	treatment: cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum for 24 hours	total RNA	RNA was extracted using the Qiagen RNeasy Kit, (Qiagen Inc.), according to the manufacturer's protocol.  On-column DNase digestion was performed.  RNA concentration, purity, and integrity was assessed by NanoDrop (Thermo Fisher Scientific Inc) and Agilent Bioanalyzer.	RNA-seq libraries were constructed from 1 ug total RNA using the Illumina TruSeq mRNA LT Sample Prep Kit according to the manufacturer’s protocol.	Barcoded libraries were pooled and sequenced on the Illumina HiSeq 2500 generating 50 bp paired end reads.	9606	LNCaP human prostate tumor cell line cultured in full growth media containing FBS	Image analysis and base calling were performed using Illumina's Real Time Analysis v1.18.64.0 software, followed by 'demultiplexing' of indexed reads and generation of FASTQ files, using Illumina's bcl2fastq Conversion Software v1.8.4	Sequencing reads were mapped to the hg19 human genome using TopHat v2.0.9 and bowtie2 v2.1.0.	Mean and standard deviation of fragment size were calculated with picard-tools v2.18.1	Transcript abundance was determined from the TopHat alignments in R using the Genomic Alignments Bioconductor package v1.6.3 using the summarizeOverlaps function with mode=IntersectionStrict, counting reads mapping to the exonic regions of genes.	Genome_build: Genome_build: hg19	Supplementary_files_format_and_content: Supplementary_files_format_and_content: *_processed_data.txt: Processed files are tab-delimited text files. Each file contains 7 columns: Entrez Gene ID, gene symbol, gene name, mRNA size, raw fragment count (by gene), FPM (fragments per million reads mapped) and FPKM (fragments per kilobase per million reads mapped).	GPL16791	Ilsa,,Coleman	icoleman@fredhutch.org	206-667-1703	Peter Nelson	Human Biology	Fred Hutchinson Cancer Center	1100 Fairview Ave N, E2-112	Seattle	WA	98109	USA	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09985056	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4649660	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3378nnn/GSM3378079/suppl/GSM3378079_LNCaP_LP_CS_A_processed_data.txt.gz	cells were cultured in phenol-red free RPMI-1640 with 10% FBS	LNCaP (ATCC CRL-1740)	prostate cancer	male	cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum for 24 hours	A
GSM3378080	LNCaP LP CS B	GSM3378080	Public on Jul 09 2019	Sep 06 2018	Jul 11 2019	SRA	1	LNCaP human prostate tumor cell line	Homo sapiens	gender: male	cell line: LNCaP (ATCC CRL-1740)	cell type: prostate cancer	cell culture media: cells were cultured in phenol-red free RPMI-1640 with 10% FBS	treatment: cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum for 24 hours	total RNA	RNA was extracted using the Qiagen RNeasy Kit, (Qiagen Inc.), according to the manufacturer's protocol.  On-column DNase digestion was performed.  RNA concentration, purity, and integrity was assessed by NanoDrop (Thermo Fisher Scientific Inc) and Agilent Bioanalyzer.	RNA-seq libraries were constructed from 1 ug total RNA using the Illumina TruSeq mRNA LT Sample Prep Kit according to the manufacturer’s protocol.	Barcoded libraries were pooled and sequenced on the Illumina HiSeq 2500 generating 50 bp paired end reads.	9606	LNCaP human prostate tumor cell line cultured in full growth media containing FBS	Image analysis and base calling were performed using Illumina's Real Time Analysis v1.18.64.0 software, followed by 'demultiplexing' of indexed reads and generation of FASTQ files, using Illumina's bcl2fastq Conversion Software v1.8.4	Sequencing reads were mapped to the hg19 human genome using TopHat v2.0.9 and bowtie2 v2.1.0.	Mean and standard deviation of fragment size were calculated with picard-tools v2.18.1	Transcript abundance was determined from the TopHat alignments in R using the Genomic Alignments Bioconductor package v1.6.3 using the summarizeOverlaps function with mode=IntersectionStrict, counting reads mapping to the exonic regions of genes.	Genome_build: Genome_build: hg19	Supplementary_files_format_and_content: Supplementary_files_format_and_content: *_processed_data.txt: Processed files are tab-delimited text files. Each file contains 7 columns: Entrez Gene ID, gene symbol, gene name, mRNA size, raw fragment count (by gene), FPM (fragments per million reads mapped) and FPKM (fragments per kilobase per million reads mapped).	GPL16791	Ilsa,,Coleman	icoleman@fredhutch.org	206-667-1703	Peter Nelson	Human Biology	Fred Hutchinson Cancer Center	1100 Fairview Ave N, E2-112	Seattle	WA	98109	USA	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09985055	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4649661	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3378nnn/GSM3378080/suppl/GSM3378080_LNCaP_LP_CS_B_processed_data.txt.gz	cells were cultured in phenol-red free RPMI-1640 with 10% FBS	LNCaP (ATCC CRL-1740)	prostate cancer	male	cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum for 24 hours	A
GSM3378081	LNCaP LP CSR100 A	GSM3378081	Public on Jul 09 2019	Sep 06 2018	Jul 11 2019	SRA	1	LNCaP human prostate tumor cell line	Homo sapiens	gender: male	cell line: LNCaP (ATCC CRL-1740)	cell type: prostate cancer	cell culture media: cells were cultured in phenol-red free RPMI-1640 with 10% FBS	treatment: cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum plus 100nM R1881 for 24 hours	total RNA	RNA was extracted using the Qiagen RNeasy Kit, (Qiagen Inc.), according to the manufacturer's protocol.  On-column DNase digestion was performed.  RNA concentration, purity, and integrity was assessed by NanoDrop (Thermo Fisher Scientific Inc) and Agilent Bioanalyzer.	RNA-seq libraries were constructed from 1 ug total RNA using the Illumina TruSeq mRNA LT Sample Prep Kit according to the manufacturer’s protocol.	Barcoded libraries were pooled and sequenced on the Illumina HiSeq 2500 generating 50 bp paired end reads.	9606	LNCaP human prostate tumor cell line cultured in full growth media containing FBS	Image analysis and base calling were performed using Illumina's Real Time Analysis v1.18.64.0 software, followed by 'demultiplexing' of indexed reads and generation of FASTQ files, using Illumina's bcl2fastq Conversion Software v1.8.4	Sequencing reads were mapped to the hg19 human genome using TopHat v2.0.9 and bowtie2 v2.1.0.	Mean and standard deviation of fragment size were calculated with picard-tools v2.18.1	Transcript abundance was determined from the TopHat alignments in R using the Genomic Alignments Bioconductor package v1.6.3 using the summarizeOverlaps function with mode=IntersectionStrict, counting reads mapping to the exonic regions of genes.	Genome_build: Genome_build: hg19	Supplementary_files_format_and_content: Supplementary_files_format_and_content: *_processed_data.txt: Processed files are tab-delimited text files. Each file contains 7 columns: Entrez Gene ID, gene symbol, gene name, mRNA size, raw fragment count (by gene), FPM (fragments per million reads mapped) and FPKM (fragments per kilobase per million reads mapped).	GPL16791	Ilsa,,Coleman	icoleman@fredhutch.org	206-667-1703	Peter Nelson	Human Biology	Fred Hutchinson Cancer Center	1100 Fairview Ave N, E2-112	Seattle	WA	98109	USA	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09985050	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4649662	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3378nnn/GSM3378081/suppl/GSM3378081_LNCaP_LP_CSR100_A_processed_data.txt.gz	cells were cultured in phenol-red free RPMI-1640 with 10% FBS	LNCaP (ATCC CRL-1740)	prostate cancer	male	cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum plus 100nM R1881 for 24 hours	B
GSM3378082	LNCaP LP CSR100 B	GSM3378082	Public on Jul 09 2019	Sep 06 2018	Jul 11 2019	SRA	1	LNCaP human prostate tumor cell line	Homo sapiens	gender: male	cell line: LNCaP (ATCC CRL-1740)	cell type: prostate cancer	cell culture media: cells were cultured in phenol-red free RPMI-1640 with 10% FBS	treatment: cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum plus 100nM R1881 for 24 hours	total RNA	RNA was extracted using the Qiagen RNeasy Kit, (Qiagen Inc.), according to the manufacturer's protocol.  On-column DNase digestion was performed.  RNA concentration, purity, and integrity was assessed by NanoDrop (Thermo Fisher Scientific Inc) and Agilent Bioanalyzer.	RNA-seq libraries were constructed from 1 ug total RNA using the Illumina TruSeq mRNA LT Sample Prep Kit according to the manufacturer’s protocol.	Barcoded libraries were pooled and sequenced on the Illumina HiSeq 2500 generating 50 bp paired end reads.	9606	LNCaP human prostate tumor cell line cultured in full growth media containing FBS	Image analysis and base calling were performed using Illumina's Real Time Analysis v1.18.64.0 software, followed by 'demultiplexing' of indexed reads and generation of FASTQ files, using Illumina's bcl2fastq Conversion Software v1.8.4	Sequencing reads were mapped to the hg19 human genome using TopHat v2.0.9 and bowtie2 v2.1.0.	Mean and standard deviation of fragment size were calculated with picard-tools v2.18.1	Transcript abundance was determined from the TopHat alignments in R using the Genomic Alignments Bioconductor package v1.6.3 using the summarizeOverlaps function with mode=IntersectionStrict, counting reads mapping to the exonic regions of genes.	Genome_build: Genome_build: hg19	Supplementary_files_format_and_content: Supplementary_files_format_and_content: *_processed_data.txt: Processed files are tab-delimited text files. Each file contains 7 columns: Entrez Gene ID, gene symbol, gene name, mRNA size, raw fragment count (by gene), FPM (fragments per million reads mapped) and FPKM (fragments per kilobase per million reads mapped).	GPL16791	Ilsa,,Coleman	icoleman@fredhutch.org	206-667-1703	Peter Nelson	Human Biology	Fred Hutchinson Cancer Center	1100 Fairview Ave N, E2-112	Seattle	WA	98109	USA	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09985059	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4649663	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3378nnn/GSM3378082/suppl/GSM3378082_LNCaP_LP_CSR100_B_processed_data.txt.gz	cells were cultured in phenol-red free RPMI-1640 with 10% FBS	LNCaP (ATCC CRL-1740)	prostate cancer	male	cells were cultured in phenol-red free RPMI-1640 with 5% charcoal-stripped serum plus 100nM R1881 for 24 hours	B
GSM3378083	LNCaP LP FBS A	GSM3378083	Public on Jul 09 2019	Sep 06 2018	Jul 11 2019	SRA	1	LNCaP human prostate tumor cell line	Homo sapiens	gender: male	cell line: LNCaP (ATCC CRL-1740)	cell type: prostate cancer	cell culture media: cells were cultured in phenol-red free RPMI-1640 with 10% FBS	treatment: cells were cultured in phenol-red free RPMI-1640 with 10% FBS for 24 hours	total RNA	RNA was extracted using the Qiagen RNeasy Kit, (Qiagen Inc.), according to the manufacturer's protocol.  On-column DNase digestion was performed.  RNA concentration, purity, and integrity was assessed by NanoDrop (Thermo Fisher Scientific Inc) and Agilent Bioanalyzer.	RNA-seq libraries were constructed from 1 ug total RNA using the Illumina TruSeq mRNA LT Sample Prep Kit according to the manufacturer’s protocol.	Barcoded libraries were pooled and sequenced on the Illumina HiSeq 2500 generating 50 bp paired end reads.	9606	LNCaP human prostate tumor cell line cultured in full growth media containing FBS	Image analysis and base calling were performed using Illumina's Real Time Analysis v1.18.64.0 software, followed by 'demultiplexing' of indexed reads and generation of FASTQ files, using Illumina's bcl2fastq Conversion Software v1.8.4	Sequencing reads were mapped to the hg19 human genome using TopHat v2.0.9 and bowtie2 v2.1.0.	Mean and standard deviation of fragment size were calculated with picard-tools v2.18.1	Transcript abundance was determined from the TopHat alignments in R using the Genomic Alignments Bioconductor package v1.6.3 using the summarizeOverlaps function with mode=IntersectionStrict, counting reads mapping to the exonic regions of genes.	Genome_build: Genome_build: hg19	Supplementary_files_format_and_content: Supplementary_files_format_and_content: *_processed_data.txt: Processed files are tab-delimited text files. Each file contains 7 columns: Entrez Gene ID, gene symbol, gene name, mRNA size, raw fragment count (by gene), FPM (fragments per million reads mapped) and FPKM (fragments per kilobase per million reads mapped).	GPL16791	Ilsa,,Coleman	icoleman@fredhutch.org	206-667-1703	Peter Nelson	Human Biology	Fred Hutchinson Cancer Center	1100 Fairview Ave N, E2-112	Seattle	WA	98109	USA	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09985058	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4649664	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3378nnn/GSM3378083/suppl/GSM3378083_LNCaP_LP_FBS_A_processed_data.txt.gz	cells were cultured in phenol-red free RPMI-1640 with 10% FBS	LNCaP (ATCC CRL-1740)	prostate cancer	male	cells were cultured in phenol-red free RPMI-1640 with 10% FBS for 24 hours	C
GSM3378084	LNCaP LP FBS B	GSM3378084	Public on Jul 09 2019	Sep 06 2018	Jul 11 2019	SRA	1	LNCaP human prostate tumor cell line	Homo sapiens	gender: male	cell line: LNCaP (ATCC CRL-1740)	cell type: prostate cancer	cell culture media: cells were cultured in phenol-red free RPMI-1640 with 10% FBS	treatment: cells were cultured in phenol-red free RPMI-1640 with 10% FBS for 24 hours	total RNA	RNA was extracted using the Qiagen RNeasy Kit, (Qiagen Inc.), according to the manufacturer's protocol.  On-column DNase digestion was performed.  RNA concentration, purity, and integrity was assessed by NanoDrop (Thermo Fisher Scientific Inc) and Agilent Bioanalyzer.	RNA-seq libraries were constructed from 1 ug total RNA using the Illumina TruSeq mRNA LT Sample Prep Kit according to the manufacturer’s protocol.	Barcoded libraries were pooled and sequenced on the Illumina HiSeq 2500 generating 50 bp paired end reads.	9606	LNCaP human prostate tumor cell line cultured in full growth media containing FBS	Image analysis and base calling were performed using Illumina's Real Time Analysis v1.18.64.0 software, followed by 'demultiplexing' of indexed reads and generation of FASTQ files, using Illumina's bcl2fastq Conversion Software v1.8.4	Sequencing reads were mapped to the hg19 human genome using TopHat v2.0.9 and bowtie2 v2.1.0.	Mean and standard deviation of fragment size were calculated with picard-tools v2.18.1	Transcript abundance was determined from the TopHat alignments in R using the Genomic Alignments Bioconductor package v1.6.3 using the summarizeOverlaps function with mode=IntersectionStrict, counting reads mapping to the exonic regions of genes.	Genome_build: Genome_build: hg19	Supplementary_files_format_and_content: Supplementary_files_format_and_content: *_processed_data.txt: Processed files are tab-delimited text files. Each file contains 7 columns: Entrez Gene ID, gene symbol, gene name, mRNA size, raw fragment count (by gene), FPM (fragments per million reads mapped) and FPKM (fragments per kilobase per million reads mapped).	GPL16791	Ilsa,,Coleman	icoleman@fredhutch.org	206-667-1703	Peter Nelson	Human Biology	Fred Hutchinson Cancer Center	1100 Fairview Ave N, E2-112	Seattle	WA	98109	USA	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09985057	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4649665	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3378nnn/GSM3378084/suppl/GSM3378084_LNCaP_LP_FBS_B_processed_data.txt.gz	cells were cultured in phenol-red free RPMI-1640 with 10% FBS	LNCaP (ATCC CRL-1740)	prostate cancer	male	cells were cultured in phenol-red free RPMI-1640 with 10% FBS for 24 hours	C
